Dr. Lucio Fumi

CEO of Wyfold Medical, United Kingdom
Dr. Lucio Fumi

Dr. Lucio Fumi, MD, is a European physician, who worked as a clinical geriatrician, and after that for over thirty years in the healthcare industry in Italy, Germany, Slovenia, the UK and the Netherlands. Registered for Medical Practice in Italy and the UK, Dr Fumi has worked as Medical Director of international corporations, to include Baxter, Abbott, Terumo and Bristol-Myers Squibb, with pharmaceutical, biotech, clinical nutrition and medical technology products.

In 1998 Dr Fumi set up Wyfold Medical, a consultancy agency dedicated to medical affairs and clinical development for the medical device and biotech industry. As interim manager, Dr Fumi worked also as Medical Director or Chief Medical Officer of BioPheresis, RanD Biotech, Astellas Pharma, Clasado Biosciences, and BTG. He is currently Global Director of Medical Affairs of Piramal Critical Care.

In the last 10 years his main focus has been in the loco-regional treatment of cancer, and specifically Interventional Oncology and Liver Cancer. More recently Dr Fumi has been President of the Italian Medical Society of Great Britain (2014-16) and Chairman of the Board of BetaGlue Technologies (2016-18). He is currently Editor-in-Chief of The Journal of Liver Research, Disorders & Therapy (JLRDT).

Go back to Agenda & Venue


For more information about your participation, please contact us at info@clinicaltrialsymposium.com or call us at +40 (0) 726 840 456

For additional information regarding partnership, sponsors & exhibitors and media, please contact our
marketing and communication department at anca.bejenaru@clinicaltrialsymposium.com or +40 (0) 726 840 456 +40 (0) 742 231 001


Subscribe to our newsletter and stay connected to news about
our symposium and AVANTYO Institute of Clinical Research!

Clinical Trials Symposium is an event organized by Avantyo Institute of Clinical Research - www.avantyo.com